Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Impact of trazodone once-a-day on quality of life and functional recovery in adults with major depressive disorder: A prospective, observational study.

Valeria Tellone | Oto Markovic | Milena Strashimirova | Gabriele Sani | William R Lenderking | Mary Kay Margolis | Raffaella Fallone | Elisa Quarchioni | Agnese Cattaneo | Alessandro Comandini
Brain and behavior | 2024

Health-related quality of life (HRQL) is an important goal for patients with major depressive disorder (MDD), but whether antidepressants improve HRQL in these patients is unclear. Here, we describe the real-world effects of trazodone once-a-day (TzOAD) and selective serotonin reuptake inhibitor (SSRI) treatments on HRQL and functioning in adults with MDD.

Pubmed ID: 39034363

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: Angelini Pharma,

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Patient-Reported Outcomes Measurement Information System (tool)

RRID:SCR_004718

Repository of person centered measures that evaluates and monitors physical, mental, and social health in adults and children.

View all literature mentions